About Bioverge
Bioverge is a Technology company based in San Francisco (United States) founded in 2016 by Neil Littman. Investments in healthcare startups are enabled via an alternative platform. The company has 2 employees. Its chief executive, as recorded, is Neil Littman. Bioverge offers products and services including Bioverge Access Fund, Deal-By-Deal Investing, and Thematic Funds. Its focus areas include FinTech, Investment Tech, Alternative Investment Platforms and Private Companies. Its legal entity is Bioverge, Inc. Its competitors include Healthcare Shares, Sana Capital and BioVentureOne; 1 of its 3 listed competitors has raised funding.
Company details
Bioverge was founded in 2016 in San Francisco, United States, as an alternative investment platform focused on healthcare startups. Investments in individual startups or Bioverge-managed funds are facilitated for users. Outside funding opportunities from third parties are provided, alongside quality screening processes to evaluate potential investments. Operations center on connecting investors with vetted healthcare sector opportunities.
- Headquarters San Francisco, United States
- Employees 2
- Founders Neil Littman
- SectorsTechnology
- Email••••••••
- Website bioverge.com
- Social LinkedIn X Facebook Instagram
- Legal Name Bioverge, Inc.
- Annual Revenue$136.25 K (USD)-45as on Apr 29, 2024
- Net Profit-$431.3 K (USD)-6as on Apr 29, 2024
- Employee Count2
Products & Services of Bioverge
Bioverge offers a comprehensive portfolio of products and services, including Bioverge Access Fund, Deal-By-Deal Investing, and Thematic Funds.
Diversified portfolio for healthcare startup investments
Select individual opportunities in healthcare ventures
Focus on areas like cancer and digital health investing
People of Bioverge
1 people are tracked at Bioverge (1 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Neil Littman | Founder & CEO | Leadership |
Complete people profiles for Bioverge
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Bioverge
Bioverge has 3 listed competitors in our database, 1 of them funded. They include Healthcare Shares, Sana Capital and BioVentureOne.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| healthcareshares.com | 2020 | Hoboken, United States | $797,501 | Crowdfunding is enabled for healthcare ventures and initiatives. | ||
| sanacapital.com | 2019 | New York, United States | Early-stage fund investing in healthcare services and technology. | |||
| bioventureone.com | 2020 | Westfield, United States | Serves as a fundraising platform for life sciences and healthcare ventures. |
Detailed competitors of Bioverge
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Investment & Financial Technology
3 companies that operate in the same segment as Bioverge (Investment & Financial Technology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Commission-free trading and investment services are provided by Robinhood. | 2013 | Menlo Park, California, United States | USD 5.58 B | USD 2.98 B | 4,841 | |
Financial data and investment advisory tools are offered online. | 1984 | Chicago, Illinois, United States | USD 91 M | USD 351.25 K | 6 | |
App-based platform for spare change investment | 2012 | Irvine, California, United States | USD 587.84 M | 602 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioverge
Complete news archive for Bioverge
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioverge
Bioverge was founded in 2016.
Bioverge is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Neil Littman is the CEO of Bioverge, as recorded in our data. They have also founded this company.
Bioverge has 2 employees.
Annual revenue of Bioverge is $136.25K as on Apr 29, 2024.
Bioverge was founded in 2016 in San Francisco, United States, as an alternative investment platform focused on healthcare startups. Investments in individual startups or Bioverge-managed funds are facilitated for users. Outside funding opportunities from third parties are provided, alongside quality screening processes to evaluate potential investments. Operations center on connecting investors with vetted healthcare sector opportunities.
Bioverge's top competitors include Healthcare Shares, Sana Capital and BioVentureOne.
Bioverge offers Bioverge Access Fund, Deal-By-Deal Investing, and Thematic Funds.
Bioverge operates through Bioverge, Inc..